Katie N Murray1, Sylvie Girard1, William M Holmes1, Laura M Parkes1, Stephen R Williams1, Adrian R Parry-Jones2, Stuart M Allan1. 1. From the Faculty of Life Sciences (K.N.M., S.M.A.) and Centre for Imaging Science (L.M.P., S.R.W.), University of Manchester, Manchester, United Kingdom; Sainte-Justine Hospital Research Centre, University of Montreal, Canada (S.G.); Glasgow Experimental MRI Centre, The University of Glasgow, Glasgow, United Kingdom (W.M.H.); and University of Manchester, Manchester Academic Health Sciences Centre, United Kingdom (A.R.P.-J.). 2. From the Faculty of Life Sciences (K.N.M., S.M.A.) and Centre for Imaging Science (L.M.P., S.R.W.), University of Manchester, Manchester, United Kingdom; Sainte-Justine Hospital Research Centre, University of Montreal, Canada (S.G.); Glasgow Experimental MRI Centre, The University of Glasgow, Glasgow, United Kingdom (W.M.H.); and University of Manchester, Manchester Academic Health Sciences Centre, United Kingdom (A.R.P.-J.). adrian.parry-jones@manchester.ac.uk.
Abstract
BACKGROUND AND PURPOSE: Systemic inflammation contributes to diverse acute and chronic brain pathologies, and extensive evidence implicates inflammation in stroke susceptibility and poor outcome. Here we investigate whether systemic inflammation alters cerebral blood flow during reperfusion after experimental cerebral ischemia. METHODS: Serial diffusion and perfusion-weighted MRI was performed after reperfusion in Wistar rats given systemic (intraperitoneal) interleukin-1β or vehicle before 60-minute transient middle cerebral artery occlusion. The expression and location of endothelin-1 was assessed by polymerase chain reaction, ELISA, and immunofluorescence. RESULTS: Systemic interleukin-1 caused a severe reduction in cerebral blood flow and increase in infarct volume compared with vehicle. Restriction in cerebral blood flow was observed alongside activation of the cerebral vasculature and upregulation of the vasoconstricting peptide endothelin-1 in the ischemic penumbra. A microthrombotic profile was also observed in the vasculature of rats receiving interleukin-1. Blockade of endothelin-1 receptors reversed this hypoperfusion, reduced tissue damage, and improved functional outcome. CONCLUSIONS: These data suggest patients with a raised inflammatory profile may have persistent deficits in perfusion after reopening of an occluded vessel. Future therapeutic strategies to interrupt the mechanism identified could lead to enhanced recovery of penumbra in patients with a heightened inflammatory burden and a better outcome after stroke.
BACKGROUND AND PURPOSE: Systemic inflammation contributes to diverse acute and chronic brain pathologies, and extensive evidence implicates inflammation in stroke susceptibility and poor outcome. Here we investigate whether systemic inflammation alters cerebral blood flow during reperfusion after experimental cerebral ischemia. METHODS: Serial diffusion and perfusion-weighted MRI was performed after reperfusion in Wistar rats given systemic (intraperitoneal) interleukin-1β or vehicle before 60-minute transient middle cerebral artery occlusion. The expression and location of endothelin-1 was assessed by polymerase chain reaction, ELISA, and immunofluorescence. RESULTS: Systemic interleukin-1 caused a severe reduction in cerebral blood flow and increase in infarct volume compared with vehicle. Restriction in cerebral blood flow was observed alongside activation of the cerebral vasculature and upregulation of the vasoconstricting peptide endothelin-1 in the ischemic penumbra. A microthrombotic profile was also observed in the vasculature of rats receiving interleukin-1. Blockade of endothelin-1 receptors reversed this hypoperfusion, reduced tissue damage, and improved functional outcome. CONCLUSIONS: These data suggest patients with a raised inflammatory profile may have persistent deficits in perfusion after reopening of an occluded vessel. Future therapeutic strategies to interrupt the mechanism identified could lead to enhanced recovery of penumbra in patients with a heightened inflammatory burden and a better outcome after stroke.
Authors: Campbell J Le Heron; Sarah L Wright; Tracy R Melzer; Daniel J Myall; Michael R MacAskill; Leslie Livingston; Ross J Keenan; Richard Watts; John C Dalrymple-Alford; Tim J Anderson Journal: J Cereb Blood Flow Metab Date: 2014-03-12 Impact factor: 6.200
Authors: M Griebe; R Kern; P Eisele; C Sick; M E Wolf; Johannes Sauter-Servaes; J Gregori; M Günther; M G Hennerici; K Szabo Journal: Cerebrovasc Dis Date: 2013-07-06 Impact factor: 2.762
Authors: Miguel D'haeseleer; Roel Beelen; Yves Fierens; Melissa Cambron; Anne-Marie Vanbinst; Christian Verborgh; Johan Demey; Jacques De Keyser Journal: Proc Natl Acad Sci U S A Date: 2013-03-18 Impact factor: 11.205
Authors: Weiguo Li; Roshini Prakash; Dhruv Chawla; Wenting Du; Sean P Didion; Jessica A Filosa; Quanguang Zhang; Darrell W Brann; Victor V Lima; Rita C Tostes; Adviye Ergul Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-04-10 Impact factor: 3.619
Authors: Jesus M Pradillo; Adam Denes; Andrew D Greenhalgh; Herve Boutin; Caroline Drake; Barry W McColl; Eleanor Barton; Spencer D Proctor; James C Russell; Nancy J Rothwell; Stuart M Allan Journal: J Cereb Blood Flow Metab Date: 2012-07-11 Impact factor: 6.200
Authors: Caroline Drake; Hervé Boutin; Matthew S Jones; Adam Denes; Barry W McColl; Johann R Selvarajah; Sharon Hulme; Rachel F Georgiou; Rainer Hinz; Alexander Gerhard; Andy Vail; Christian Prenant; Peter Julyan; Renaud Maroy; Gavin Brown; Alison Smigova; Karl Herholz; Michael Kassiou; David Crossman; Sheila Francis; Spencer D Proctor; James C Russell; Stephen J Hopkins; Pippa J Tyrrell; Nancy J Rothwell; Stuart M Allan Journal: Brain Behav Immun Date: 2011-02-26 Impact factor: 7.217
Authors: Pia M Vidal; Spyridon K Karadimas; Antigona Ulndreaj; Alex M Laliberte; Lindsay Tetreault; Stefania Forner; Jian Wang; Warren D Foltz; Michael G Fehlings Journal: JCI Insight Date: 2017-06-02